Compare Lowe`s Companies Inc (LOW) vs Medpace Holdings Inc (MEDP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Lowe`s Companies Inc vs Medpace Holdings Inc — how do they compare? Lowe`s Companies Inc trades at $221.22 (market cap $124.06B), while Medpace Holdings Inc trades at $607 (market cap $16.90B). The key difference: Lowe`s Companies Inc is far larger — about 7.3× Medpace Holdings Inc's market cap, and Lowe`s Companies Inc pays a 2.26% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| LOW | MEDP | |
|---|---|---|
Market Cap | $124.06B | $16.90B |
Sector | Consumer Cyclical | Technology |
52-Week High | $287.39 | $620.59 |
52-Week Low | $201.92 | $393.42 |
Enterprise Value | $165.81B | $16.52B |
Dividend Yield | 2.26% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Lowe`s Companies Inc
Lowe's is the second-largest home improvement retailer in the world, operating 1,969 stores and servicing around 230 dealer-owned stores throughout the United States and Canada. The firm's stores offer products and services for home decorating, maintenance, repair, and remodeling, with maintenance and repair accounting for two thirds of products sold. Lowe's targets retail do-it-yourself (around 75% of sales) and do-it-for-me customers as well as commercial and professional business clients (around 25% of sales). We estimate Lowe's captures a low-double-digit share of the domestic home improvement market, based on U.S. Census data and management's estimates for market size.
Read more on LOW →About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →
